Show simple item record

dc.contributor.author
Hutmacher, Cornelia
dc.contributor.author
Volta, Laura
dc.contributor.author
Rinaldi, Francesco
dc.contributor.author
Murer, Patrizia
dc.contributor.author
Myburgh, Renier
dc.contributor.author
Manz, Markus G.
dc.contributor.author
Neri, Dario
dc.date.accessioned
2019-08-08T16:48:36Z
dc.date.available
2019-08-03T02:34:54Z
dc.date.available
2019-08-08T16:47:28Z
dc.date.available
2019-08-08T16:48:36Z
dc.date.issued
2019-09
dc.identifier.issn
0145-2126
dc.identifier.other
10.1016/j.leukres.2019.106178
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/356420
dc.language.iso
en
en_US
dc.publisher
Elsevier
en_US
dc.subject
acute myeloid leukemia
en_US
dc.subject
CD123
en_US
dc.subject
Antibody therapeutics
en_US
dc.subject
Bispecific antibodies
en_US
dc.subject
Antibody-dependent cell cytotoxicity (ADCC)
en_US
dc.subject
CD3
en_US
dc.title
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia
en_US
dc.type
Journal Article
dc.date.published
2019-06-27
ethz.journal.title
Leukemia Research
ethz.journal.volume
84
en_US
ethz.journal.abbreviated
Leuk Res
ethz.pages.start
106178
en_US
ethz.size
9 p.
en_US
ethz.grant
Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature
en_US
ethz.grant
Fulfilling Paul Ehrlich’s Dream: therapeutics with activation on demand
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
Oxford
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
ethz.grant.agreementno
163479
ethz.grant.agreementno
670603
ethz.grant.fundername
SNF
ethz.grant.fundername
EC
ethz.grant.funderDoi
10.13039/501100001711
ethz.grant.funderDoi
10.13039/501100000780
ethz.grant.program
Exzellenzbeitrag in Lebenswissenschaften
ethz.grant.program
H2020
ethz.date.deposited
2019-08-03T02:35:07Z
ethz.source
SCOPUS
ethz.eth
yes
en_US
ethz.availability
Metadata only
en_US
ethz.rosetta.installDate
2019-08-08T16:47:41Z
ethz.rosetta.lastUpdated
2023-02-06T17:29:35Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Development%20of%20a%20novel%20fully-human%20anti-CD123%20antibody%20to%20target%20acute%20myeloid%20leukemia&rft.jtitle=Leukemia%20Research&rft.date=2019-09&rft.volume=84&rft.spage=106178&rft.issn=0145-2126&rft.au=Hutmacher,%20Cornelia&Volta,%20Laura&Rinaldi,%20Francesco&Murer,%20Patrizia&Myburgh,%20Renier&rft.genre=article&rft_id=info:doi/10.1016/j.leukres.2019.106178&
 Search print copy at ETH Library

Files in this item

FilesSizeFormatOpen in viewer

There are no files associated with this item.

Publication type

Show simple item record